A3309
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for A3309, covering 2024-03-07 to 2024-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of A3309 in Patients With Dyslipidemia [Phase 2]